Skip to content
HowShorted

Viking Therapeutics, Inc. short interest in 2022

In 2022, Viking Therapeutics, Inc.'s disclosed short interest ran from 4.65% of shares outstanding on 14 Jan 2022 to 2.47% on 15 Dec 2022, a change of -2.18 percentage points. The year's high was 6.06% on 31 May 2022 and its low 2.31% on 30 Nov 2022, averaging 3.94% across 23 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 5.72 days on 15 Mar 2022. Full history: Viking Therapeutics, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Viking Therapeutics, Inc. in 2022

2022 in figures

Start of year
4.65% (14 Jan 2022)
End of year
2.47% (15 Dec 2022)
Change
-2.18 pp
High
6.06% (31 May 2022)
Low
2.31% (30 Nov 2022)
Average
3.94%
Highest days to cover
5.72 (15 Mar 2022)
SEC filings marked
8

Every report in 2022

Viking Therapeutics, Inc. short interest in 2022
SettlementShort interestDays to coverFilings since previous
14 Jan 20224.65%3.24
31 Jan 20225.52%2.85
15 Feb 20225.29%3.6710-K filed, results (8-K)
28 Feb 20225.56%3.82
15 Mar 20225.70%5.72
31 Mar 20224.55%2.79
14 Apr 20224.72%4.71
29 Apr 20224.98%4.0010-Q filed, results (8-K)
13 May 20225.80%5.13
31 May 20226.06%5.12
15 Jun 20225.95%4.63
30 Jun 20223.50%1.46
15 Jul 20223.19%2.06
29 Jul 20222.83%1.9910-Q filed, results (8-K)
15 Aug 20222.73%2.79
31 Aug 20222.64%5.40
15 Sep 20222.51%4.74
30 Sep 20222.45%3.66
14 Oct 20222.33%3.19
31 Oct 20222.47%1.4610-Q filed, results (8-K)
15 Nov 20222.35%1.72
30 Nov 20222.31%2.75
15 Dec 20222.47%3.35

See also: Viking Therapeutics, Inc.'s full history · most shorted US stocks of 2022 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.